Dr. Therkelsen is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
875 Blake Wilbur Dr
Palo Alto, CA 94304
Education & Training
Memorial Sloan Kettering Cancer CenterFellowship, Neuro-Oncology, 2020 - 2022
Stanford Health Care-Sponsored Stanford UniversityResidency, Neurology, 2017 - 2020
Mount Auburn HospitalInternship, Internal Medicine, 2016 - 2017
Boston University School of MedicineClass of 2016
Certifications & Licensure
CA State Medical License 2018 - 2025
NY State Medical License 2020 - 2023
MA State Medical License 2016 - 2017- American Board of Psychiatry and Neurology Neurology
Clinical Trials
- ONC201 in H3 K27M-mutant Diffuse Glioma Following Radiotherapy (the ACTION Study) Start of enrollment: 2023 Jan 23
Roles: Principal Investigator, Contact
Publications & Presentations
PubMed
- Advances in Primary Central Nervous System Lymphoma.Kate E Therkelsen, Antonio Omuro
Current Neurology and Neuroscience Reports. 2024-11-25 - 2 citationsLong-term Outcomes in Primary CNS Lymphoma After R-MVP and High-Dose Chemotherapy With Autologous Hematopoietic Stem Cell Transplant.Kate Elizabeth Therkelsen, Lauren R Schaff, Subhiksha Nandakumar, Antonio M P Omuro, Lisa M DeAngelis
Neurology. 2023-08-15 - 1 citationsReal-world risk of brain metastases in stage III non-small cell lung cancer in the era of PET and MRI staging.Saud Alhusaini, Tyler A Lanman, Ryan B Ko, Kate E Therkelsen, Rie Von Eyben
Frontiers in Oncology. 2023-01-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
